• Wed, December 19, 2018
  • Wed, December 26, 2018
  • Thu, December 27, 2018
  • Fri, December 21, 2018
  • Thu, December 20, 2018

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $125 on, Dec 19th, 2018

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $185 to $125 on, Dec 19th, 2018.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Michael Schmidt of "Leerink Swann" Initiated at Buy and Held Target at $145 on, Wednesday, November 28th, 2018